Skip to main content

Table 6 Resolution rates in control and intervention groups by clinical condition and specific reminders

From: Effectiveness of electronic point-of-care reminders versus monthly feedback to improve adherence to 10 clinical recommendations in primary care: a cluster randomized clinical trial

 

Resolution (%)

OR (95% CI)

Clinical condition

Type of reminder

Total

Control group

Intervention group

Type 2 diabetes mellitus

Screen for diabetic retinopathy

23.88

20.05

27.52

1.51 (1.46–1.57)

Measure glycated hemoglobin

26.23

25.32

27.11

1.1 (1.07–1.13)

Heart failure/ischemic heart disease

Treat with beta blocker

14.64

12.58

16.61

1.38 (1.32–1.44)

Heart failure

Treat with ACEI/ARB

24.53

21.51

27.35

1.37 (1.27–1.48)

High blood pressure

Measure blood pressure

30.19

27

33.24

1.35 (1.33–1.36)

Hepatitis C

Hepatitis B vaccine

5.59

4.99

6.2

1.26 (1.1–1.43)

Atrial fibrillation

Treat with antiplatelet drug/anticoagulant

31.41

28.97

33.76

1.25 (1.15–1.36)

Cerebrovascular accident/ischemic heart disease

Treat with antiplatelet drug

33.32

30.75

35.72

1.25 (1.18–1.32)

Measure LDL cholesterol

27.19

25.71

28.63

1.16 (1.13–1.19)

Smoking

Encourage smoking cessation

12.04

11.42

12.66

1.12 (1.09–1.16)

  1. Abbreviations: ACEI Angiotensin-converting enzyme inhibitor, ARB Angiotensin II receptor blocker, LDL Low-density lipoprotein